SHAREHOLDER ALERT: WeissLaw LLP Reminds PAND, VKIN, CLGX, and VGAC Shareholders About Its Ongoing Investigations

NEW YORK, March 4, 2021 /PRNewswire/ --

If you own shares in any of the companies listed above and
would like to discuss our investigations or have any questions concerning
this notice or your rights or interests, please contact:

Joshua Rubin, Esq.
WeissLaw LLP
1500 Broadway, 16^th Floor
New York, NY 10036
(212) 682-3025
(888) 593-4771
[email protected]

Pandion Therapeutics, Inc. (NASDAQ: PAND)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Pandion Therapeutics, Inc. (NASDAQ: PAND) in connection with the proposed acquisition of the company Merck Sharp & Dohme Corp. Under the terms of the merger agreement, PAND shareholders will receive $60.00 in cash for each share of PAND common stock that they hold. If you own PAND shares and wish to discuss this investigation or your rights, please call or visit our website: http://www.weisslawllp.com/pand/

Viking Energy Group, Inc. (OTC: VKIN)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Viking Energy Group, Inc. (OTC: VKIN) in connection with the company's proposed merger with Camber Energy, Inc. (NYSE: CEI). Under the terms of the merger agreement, which is structured as a reverse merger, Camber will issue newly-issued shares of common stock in exchange for the balance of Viking's common stock on a one-for-one basis. Camber currently owns approximately 62% of Viking's issued and outstanding common shares. If you own VKIN shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://www.weisslawllp.com/vkin/

CoreLogic, Inc. (NYSE: CLGX)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of CoreLogic, Inc. (NYSE: CLGX) in connection with the proposed acquisition of the company by funds managed by Stone Point Capital and Insight Partners. Under the terms of the agreement, CLGX shareholders will receive $80.00 in cash for each share of CLGX common stock that they own. If you own CLGX shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://www.weisslawllp.com/clgx/

VG Acquisition Corp. (NYSE: VGAC)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of VG Acquisition Corp. (NYSE: VGAC) in connection with the company's proposed merger with 23andMe, Inc. ("23andMe"). Under the terms of the merger agreement, VGAC will acquire 23andMe through a reverse merger that will result in 23andMe becoming a public company traded on the NYSE. If you own VGAC shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://www.weisslawllp.com/vgac/

SOURCE WeissLaw LLP

Related Links

http://weisslawllp.com